Видео ютуба по тегу Valeant Pharmaceuticals

Valeant Pharmaceuticals CEO: New Products, New Name | Mad Money | CNBC
Valeant Pharmaceuticals CEO: New Products, New Name | Mad Money | CNBC
Valeant CEO on Drug Price Hikes: We Made Mistakes
Valeant CEO on Drug Price Hikes: We Made Mistakes
The Valeant Fraud Explained
The Valeant Fraud Explained
Valeant Pharmaceuticals: The Secret Pharmacy Scandal
Valeant Pharmaceuticals: The Secret Pharmacy Scandal
Valeant changes name to Bausch Health Companies, CEO explains why
Valeant changes name to Bausch Health Companies, CEO explains why
Valeant Scandal: How Valeant Scammed People Legally | Beyond Wonder
Valeant Scandal: How Valeant Scammed People Legally | Beyond Wonder
New To Valeant? Here's What Happened
New To Valeant? Here's What Happened
Bill Ackman on Valeant: Mistakes Were Made
Bill Ackman on Valeant: Mistakes Were Made
Valeant Pharmaceuticals in crosshairs of U.S. Congress
Valeant Pharmaceuticals in crosshairs of U.S. Congress
Valeant Pharmaceuticals International v. Jerney Case Brief Summary | Law Case Explained
Valeant Pharmaceuticals International v. Jerney Case Brief Summary | Law Case Explained
Valeant — spotting the dangers | Lex
Valeant — spotting the dangers | Lex
Valeant Suffers Biggest Drop on Record, What's Next?
Valeant Suffers Biggest Drop on Record, What's Next?
A Valeant Tug of War
A Valeant Tug of War
Forensic Talk; NetFlix “Dirty Money” Valeant Drugs
Forensic Talk; NetFlix “Dirty Money” Valeant Drugs
Charlie Munger: Sewer too light a word for Valeant
Charlie Munger: Sewer too light a word for Valeant
The Valeant Pharmaceuticals Fraud | Full Story | Accha FM Podcasts
The Valeant Pharmaceuticals Fraud | Full Story | Accha FM Podcasts
Heard: Valeant Gives Investors Headaches
Heard: Valeant Gives Investors Headaches
The Rise and Fall of Valeant Pharmaceuticals: Business Case Study Explained
The Rise and Fall of Valeant Pharmaceuticals: Business Case Study Explained
Valeant Pharmaceuticals CEO: Challenging Comeback | Mad Money | CNBC
Valeant Pharmaceuticals CEO: Challenging Comeback | Mad Money | CNBC
Nestle gets deeper into dermatology with Valeant deal - economy
Nestle gets deeper into dermatology with Valeant deal - economy